Gillian McGovern is an associate editor at Pharmacy Times®. She graduated from Rowan University in 2023 with a BA in Writing Arts and concentrations in Publishing & Writing for the Public, Technical & Professional Writing, and Creative Writing.
FDA Approves Sodium Oxybate to Treat Cataplexy or EDS in Pediatric Patients With Narcolepsy
Published: October 17th 2024 | Updated: October 17th 2024Patients aged 7 years and older can now be treated for their cataplexy or excessive daytime sleepiness with the extended-release oral formulation.
Read More
FDA Approves Foscarbidopa/Foslevodopa for Motor Fluctuations in Adults With Parkinson Disease
Published: October 17th 2024 | Updated: October 17th 2024This approval makes foscarbidopa/foslevodopa the first and only subcutaneous 24-hour infusion of levodopa-based therapy for adults with Parkinson disease.
Read More
Increases in Pre-Term Birth Rates Observed in All Races, Higher Increases in Minority Groups
October 9th 2024The highest pre-term birth rates were consistently observed among those who were Black, American Indian or Alaska Native, or Native Hawaiian or other Pacific islander with public insurance.
Read More
Expert: Patients With C. difficile Can Have Difficulty Advocating For Themselves
September 30th 2024C. diff survivor and Peggy Lillis Foundation Board Member Maryann Webb discusses how her experience with the infection encouraged her to advocate for patients who are struggling to advocate for themselves.
Read More
Survey Shows HCPs Are Preferred Source For Contraceptive Information Among AYAs
September 30th 2024The survey demonstrated that adolescents and young adults (AYAs) who preferred health care professionals (HCPs) as sources of information had sufficient knowledge of contraception options available.
Read More